Welcome Vikram! You'll Learn a lot in here, so come in often !!!🙂
May 5, 2025 (edited)
Yes, multiple myeloma can become refractory (stop responding) to initial treatment even while you're still undergoing therapy. This is known as refractory myeloma. When this happens, your oncologist will need to review your treatment history and consider alternative treatment options.
The goal of treatment is to reduce Show Full Answer
Yes, multiple myeloma can become refractory (stop responding) to initial treatment even while you're still undergoing therapy. This is known as refractory myeloma. When this happens, your oncologist will need to review your treatment history and consider alternative treatment options.
The goal of treatment is to reduce minimal residual disease (MRD) as much as possible. Although treatments are generally effective at killing most myeloma cells, even a few surviving cells can lead to a relapse or treatment resistance. If you notice any new or worsening symptoms during treatment - even minor ones - it's important to inform your healthcare team right away. They can perform laboratory tests to check if the treatment is still working effectively or if adjustments need to be made to your treatment plan. There are multiple therapy options available if your current treatment isn't providing the desired results.
May 5, 2025
Join
Your Privacy Choices
